SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000936392-07-000965
Filing Date
2007-12-21
Accepted
2007-12-21 16:42:39
Documents
4
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-Q a36590e10vqza.htm 10-Q/A 511685
2 EXHIBIT 31.1 a36590exv31w1.htm EX-31.1 8185
3 EXHIBIT 31.2 a36590exv31w2.htm EX-31.2 8209
4 EXHIBIT 32 a36590exv32.htm EX-32 4102
  Complete submission text file 0000936392-07-000965.txt   533709
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-15803 | Film No.: 071323712
SIC: 2834 Pharmaceutical Preparations